Cart
sales@molnova.com
Amiprilose
CAS No. 56824-20-5
Amiprilose( —— )
Catalog No. M34050 CAS No. 56824-20-5
Amiprilose (SM 1213) has anti-inflammatory activity and inhibits the proliferation of a variety of hyperproliferative cell types.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAmiprilose
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmiprilose (SM 1213) has anti-inflammatory activity and inhibits the proliferation of a variety of hyperproliferative cell types.
-
DescriptionAmiprilose (SM1213; Therafectin) is a potent inhibitor against Hepatocellular carcinoma (HCC). Amiprilose induces lymphokine-induced macrophage activation directly to kill Listeria monocytogenes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56824-20-5
-
Formula Weight305.37
-
Molecular FormulaC14H27NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(CCCN(C)C)[C@@H]1[C@@]2([C@](O[C@@]1([C@@H](CO)O)[H])(OC(C)(C)O2)[H])[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang XK, et al. Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma. J Cancer. 2020 Aug 25;11(20):6140-6156. ?
molnova catalog
related products
-
Paromomycin Sulfate
Paromomycin Sulfate is an aminoglycoside antibiotics inhibiting protein synthesis in non-resistant cells by binding to 16S ribosomal RNA.
-
N-Butanoyl-L-homoser...
N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
N-Acetyl-D-mannosami...
N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.
